Literature DB >> 25982881

Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1.

Christoph Koentges1, Alexandra König, Katharina Pfeil, Maximilian E Hölscher, Tilman Schnick, Adam R Wende, Andrea Schrepper, Maria C Cimolai, Sophia Kersting, Michael M Hoffmann, Judith Asal, Moritz Osterholt, Katja E Odening, Torsten Doenst, Lutz Hein, E Dale Abel, Christoph Bode, Heiko Bugger.   

Abstract

Hypoadiponectinemia is an independent predictor of cardiovascular disease, impairs mitochondrial function in skeletal muscle, and has been linked to the pathogenesis of Type 2 diabetes. In models of Type 2 diabetes, myocardial mitochondrial function is impaired, which is improved by increasing serum adiponectin levels. We aimed to define the roles of adiponectin receptor 1 (AdipoR1) and 2 (AdipoR2) in adiponectin-evoked regulation of mitochondrial function in the heart. In isolated working hearts in mice lacking AdipoR1, myocardial oxygen consumption was increased without a concomitant increase in cardiac work, resulting in reduced cardiac efficiency. Activities of mitochondrial oxidative phosphorylation (OXPHOS) complexes were reduced, accompanied by reduced OXPHOS protein levels, phosphorylation of AMP-activated protein kinase, sirtuin 1 activity, and peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) signaling. Decreased ATP/O ratios suggested myocardial mitochondrial uncoupling in AdipoR1-deficient mice, which was normalized by lowering increased mitochondrial 4-hydroxynonenal levels following treatment with the mitochondria-targeted antioxidant Mn (III) tetrakis (4-benzoic acid) porphyrin. Lack of AdipoR2 did not impair mitochondrial function and coupling in the heart. Thus, lack of AdipoR1 impairs myocardial mitochondrial function and coupling, suggesting that impaired AdipoR1 signaling may contribute to mitochondrial dysfunction and mitochondrial uncoupling in Type 2 diabetic hearts.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25982881     DOI: 10.1007/s00395-015-0495-4

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  12 in total

1.  The valosin-containing protein protects the heart against pathological Ca2+ overload by modulating Ca2+ uptake proteins.

Authors:  Shaunrick Stoll; Jing Xi; Ben Ma; Christiana Leimena; Erik J Behringer; Gangjian Qin; Hongyu Qiu
Journal:  Toxicol Sci       Date:  2019-07-31       Impact factor: 4.849

Review 2.  Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.

Authors:  Yajing Wang; Xin L Ma; Wayne Bond Lau
Journal:  Trends Endocrinol Metab       Date:  2017-05-01       Impact factor: 12.015

3.  The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.

Authors:  Yaeni Kim; Ji Hee Lim; Min Young Kim; Eun Nim Kim; Hye Eun Yoon; Seok Joon Shin; Bum Soon Choi; Yong-Soo Kim; Yoon Sik Chang; Cheol Whee Park
Journal:  J Am Soc Nephrol       Date:  2018-01-12       Impact factor: 10.121

4.  Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.

Authors:  Christoph Koentges; Mark E Pepin; Carolyn Müsse; Katharina Pfeil; Sonia V Viteri Alvarez; Natalie Hoppe; Michael M Hoffmann; Katja E Odening; Samuel Sossalla; Andreas Zirlik; Lutz Hein; Christoph Bode; Adam R Wende; Heiko Bugger
Journal:  Basic Res Cardiol       Date:  2017-12-29       Impact factor: 17.165

5.  Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs.

Authors:  Paul Holvoet; Maarten Vanhaverbeke; Benjamine Geeraert; Dieuwke De Keyzer; Maarten Hulsmans; Stefan Janssens
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

6.  Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1.

Authors:  Mark E Pepin; Christoph Koentges; Katharina Pfeil; Johannes Gollmer; Sophia Kersting; Sebastian Wiese; Michael M Hoffmann; Katja E Odening; Constantin von Zur Mühlen; Philipp Diehl; Peter Stachon; Dennis Wolf; Adam R Wende; Christoph Bode; Andreas Zirlik; Heiko Bugger
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-13       Impact factor: 5.555

Review 7.  Diabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore.

Authors:  Konstantin N Belosludtsev; Natalia V Belosludtseva; Mikhail V Dubinin
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

Review 8.  Adipokines and Inflammation: Focus on Cardiovascular Diseases.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Sandra Moraña-Fernández; Laura Anido-Varela; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Isabel Moscoso; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

Review 9.  Coronary Heart Disease in Type 2 Diabetes Mellitus: Genetic Factors and Their Mechanisms, Gene-Gene, and Gene-Environment Interactions in the Asian Populations.

Authors:  Khairul Anwar Zarkasi; Nor Azian Abdul Murad; Norfazilah Ahmad; Rahman Jamal; Noraidatulakma Abdullah
Journal:  Int J Environ Res Public Health       Date:  2022-01-06       Impact factor: 3.390

Review 10.  Mitochondrial Mechanisms in Diabetic Cardiomyopathy.

Authors:  Johannes Gollmer; Andreas Zirlik; Heiko Bugger
Journal:  Diabetes Metab J       Date:  2020-02       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.